Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prolonged Isotretinoin Therapy in Patients With High Risk Neuroblastoma

NCT01319838 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT01319838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01319838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prolonged Isotretinoin Therapy in Patients With High Risk Neuroblastoma
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Withdrawn
Start date
March 31, 2011
Completion date
December 31, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma